en · de · es
glossary-desk.peptides9000.com › Info › Chemical Identity Of Ghk-cu — Field Notes

Chemical Identity Of Ghk-cu — Field Notes

By Editorial Desk · published 2026-05-28 · last reviewed 2026-06-22 · Info

lyophilisation is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.

Last reviewed on 2026-06-22. Where a claim depends on a specific study, the study is described rather than over-claimed.

Chemical Identity Of GHK-Cu

The sequence now called GHK was first reported in the early 1970s after isolation from human plasma, where it was noted to influence liver cell behavior in laboratory preparations. Later work described a copper-binding form and its activity in fibroblast and wound-model experiments. Review articles frequently group the substance with other copper peptides. Concentrations in blood appear to fall with age in several small surveys, although the reason for this trend is not settled. Whether such a decline carries functional consequences remains an open question.

Published work on GHK-Cu concentrates largely on cell culture systems rather than whole organisms. Frequently used endpoints include collagen synthesis, expression of matrix metalloproteinases, and migration of fibroblasts. Some reports describe antioxidant behavior, while others stress delivery of copper into cells. These mechanisms are proposed rather than demonstrated, and the relative weight of each pathway is unclear. Human trials are few and generally small, so laboratory findings should not be read as confirmed clinical results.

GHK-Cu is a coordination complex formed between the tripeptide glycyl-L-histidyl-L-lysine and a copper(II) ion. The peptide backbone consists of glycine, histidine, and lysine joined in that order. Copper is held through the imidazole nitrogen of histidine and the alpha-amino group at the N-terminus, which together produce a square-planar arrangement around the metal center. The solid appears blue to violet, a color that originates from d-d electronic transitions within the copper coordination sphere. The complex is indexed under CAS number 89030-95-5.

Mechanism and Evidence Base

Published work on GHK-Cu is dominated by in vitro experiments and small animal studies. Human trials tend to be short and small, with endpoints such as skin appearance rather than clinical outcomes. Review articles often summarize the same underlying laboratory findings, which can make the evidence base look broader than it is. Several basic questions remain open: the concentration of the intact complex in human tissue, the route by which it crosses the skin barrier, and whether effects seen in culture produce measurable changes in people.

Laboratory studies describe GHK-Cu as a source of copper that cells can take up, with reported effects on collagen, elastin, and glycosaminoglycan synthesis in cultured fibroblasts. The peptide also appears in wound-repair research, where it is linked to the activity of matrix metalloproteinases and their inhibitors. These observations come largely from cell and animal models. How directly the complex controls any single pathway in intact human skin remains an open question, and reported effects depend on concentration, vehicle, and exposure time.

Copper takes part in redox chemistry, and the same property that makes it useful in enzymes can generate reactive oxygen species when the ion is loosely bound. GHK chelates copper through imidazole, amino, and amide nitrogen donors, which reduces the amount of free copper in solution. Whether that chelation is protective, neutral, or harmful in a given tissue is not settled. Laboratory assays report both antioxidant and pro-oxidant behavior, depending on the conditions and the readout used.

Ghk-cu at a glance

PropertyValueNotes
Chemical classCopper(II) peptide complexPeptide chain coordinated to a single metal ion
CAS number89030-95-5Indexed for the peptide-copper complex
Molecular formulaC14H22CuN6O4Approximate formula for a one-to-one complex
AppearanceBlue to violet solidColor from copper d-d transitions
Solubility classFreely soluble in waterAlso dispersible in some polar solvents

Stability, Handling, and Measurement

Practical handling notes centre on limiting exposure to water, oxygen, and repeated temperature cycling. Weighed powder is often equilibrated to room temperature before opening to avoid condensation on the solid. Working solutions are typically divided into single-use aliquots and frozen rather than stored refrigerated for long periods. Reported shelf lives vary widely between laboratories, and no single set of conditions is universally treated as a reference standard, which complicates direct comparison of published stability figures.

Solutions of GHK-Cu respond strongly to pH, redox conditions, and the presence of competing chelators such as EDTA. Below roughly pH 4 the copper tends to dissociate, because the amide nitrogen donors become protonated and can no longer coordinate. Strongly alkaline conditions instead favour hydrolysis and precipitation of copper hydroxide. Dissolved oxygen and light accelerate breakdown of the peptide backbone, and the copper released during that process can catalyse further oxidation, so dry, cold, dark storage is the usual recommendation.

Related pages on this site

Copper Tripeptide Complex Background

Published studies describe the complex in several research contexts, including collagen synthesis, antioxidant behaviour, and wound repair models. Much of this work is conducted in cultured cells or in small animal systems, and the findings are frequently cited in reviews of copper peptides. Direct clinical evidence in humans is comparatively limited, and reported outcomes vary with formulation and study design. Whether free chain or metal-bound form was used is not always stated, a point that complicates comparison between reports.

GHK-Cu is a coordination complex formed between the peptide glycyl-L-histidyl-L-lysine and a copper(II) ion. The unbound chain, abbreviated GHK, consists of three amino acids and occurs naturally in human plasma, saliva, and urine. Binding of the metal is mediated mainly by the imidazole nitrogen of the histidine residue together with backbone amides, producing a stable chelate. Ingredient nomenclature often lists the same substance as copper tripeptide-1. Its charge and solubility behaviour differ from those of the metal-free chain.

The copper-binding activity of this sequence was described in the 1970s during studies of liver tissue and plasma factors. Early work identified the peptide as a component that influenced copper uptake by cells and that appeared in wound fluid. Later investigations examined its presence across species, reporting the same chain in human and animal samples. A decline in measured concentration with age became a recurring observation, although the underlying causes remain incompletely characterised.

Stability, Storage, and Analytical Control

Material described as GHK-Cu appears in several distinct markets, including cosmetic ingredients, laboratory reagents, and consumer products, and the quality expectations attached to each differ. A certificate of analysis generally reports peptide purity by chromatography, copper content, appearance, and residual solvents or counterions. Counterion identity matters, because the complex is usually supplied as an acetate or a similar salt, and the counterion contributes to the measured mass. Independent verification of sequence and metal stoichiometry is advisable when a material is used for quantitative work. Batch-to-batch variation is common and should be documented rather than assumed negligible.

Copper peptide solutions tend to resist degradation better than many free peptides, because the bound metal protects the N-terminus and reduces susceptibility to some peptidases. Backbone hydrolysis, oxidation of the histidine imidazole ring, and photochemical reactions remain the principal degradation routes. Aqueous solutions are generally most stable near neutral to mildly acidic pH, while strongly alkaline conditions accelerate hydrolysis. Light exposure is usually avoided, since both the peptide and the copper center can take part in photochemical processes. Stability data published by suppliers often describe short-term behavior rather than multi-year shelf life.

Identity and purity are commonly assessed by reversed-phase high-performance liquid chromatography, frequently paired with mass spectrometry to confirm the molecular ion. Copper content is measured separately, typically by inductively coupled plasma mass spectrometry or atomic absorption spectroscopy, because the chromatographic signal reports the peptide rather than the metal. Ultraviolet-visible spectroscopy provides a fast check on complex formation, since copper(II) peptide complexes absorb in the visible region. Elemental analysis and amino acid analysis are used less often but remain useful for reference standards. A gap between reported peptide purity and measured copper content is a recurring source of confusion.

Notes from published material

A review of four studies on the effectiveness of mindfulness-based cognitive therapy (MBCT), a recently developed class-based program designed to prevent relapse, suggests that MBCT may have an additive effect when provided with the usual care in patients who have had three or more depressive episodes, although the usual care did not include antidepressant treatment or any psychotherapy, and the improvement observed may have reflected non-specific or placebo effects. Of note, although Mindfulness-based cognitive therapy for depression prevented relapse of future depressive episodes, there is no research on whether it can cause the remission of a current depressive episode. Interpersonal psychotherapy (IPT) focuses on the social and interpersonal triggers that may cause depression. There is evidence that it is an effective treatment for depression. Here, the therapy takes a fairly structured course (often 12 sessions, as in the original research versions) as in the case with CBT; however, the focus is on relationships with others. Unlike family therapy, IPT is an individual format, so it is possible to work on interpersonal themes even if other family members do not come to the session. Therapy can be used to help a person develop or improve interpersonal skills in order to allow him or her to communicate more effectively and reduce stress. In a meta-analysis of 16 studies and 4,356 patients, the average improvement in depressive symptoms was an effect size of d = 0.63 (95% CI, 0.36 to 0.90).

=== Education === Al-Fawzan enrolled in the public school in Ash-Shamasiyyah in 1950 (1369 AH). He completed his education at Al-Faysaliyyah School in Buraydah in 1952 (1371 AH), and was appointed as a primary school teacher. He then enrolled at the Ma'had Al-'Ilmī (The Institute of Knowledge) in Buraydah when it opened in 1954 (1373 AH), and graduated from it in 1958 (1377 AH). He joined the Kullīyat Ash-Sharīʿah (The College of Sharīʿah) in Riyadh and graduated in 1962 (1381 AH). Al-Fawzan later obtained a master’s degree in fiqh in the field of inheritance law, with a thesis titled: "Al-Taḥqīqāt Al-Marḍiyyah fī Al-Mabāḥith Al-Farḍiyyah" (A Satisfactory investigation into the issues of obligatory Shares in Inheritance). He subsequently obtained a doctorate in fiqh from the same college, with a dissertation titled: "Aḥkām Al-Aṭʿimah fī Al-Sharīʿah Al-Islāmiyyah" (The Rulings of Foods in the Islamic Sharīʿah).

Glucose-6-phosphate dehydrogenase deficiency (G6PDD), also known as favism, is the most common enzyme deficiency anemia worldwide. It is an inborn error of metabolism that predisposes to red blood cell breakdown. Most of the time, those who are affected have no symptoms. Following a specific trigger, symptoms such as yellowish skin, dark urine, shortness of breath, and feeling tired may develop. Complications can include anemia and newborn jaundice. Some people never have symptoms. It is an X-linked recessive disorder that results in defective glucose-6-phosphate dehydrogenase enzyme. Glucose-6-phosphate dehydrogenase is an enzyme that protects red blood cells, which carry oxygen from the lungs to tissues throughout the body, from reactive oxygen species. An enzyme defect results in the premature breakdown of red blood cells. This destruction of red blood cells is called hemolysis. Red blood cell breakdown may be triggered by infections, certain medication, stress, or foods such as fava beans. Depending on the specific mutation the severity of the condition may vary. Diagnosis is based on symptoms and supported by blood tests and genetic testing. Affected persons must avoid dietary triggers, notably fava beans. This can be difficult, as fava beans may be called "broad beans" and are used in many foods, whole or as flour. Falafel is probably the best known, but fava beans are often used as filler in meatballs and other foods. Treatment of acute episodes may include medications for infection, stopping the offending medication, or blood transfusions.

As all 19 hijackers died in the attacks, they were never prosecuted. Osama bin Laden was never formally indicted; he was ultimately killed by U.S. special operations forces on May 2, 2011, in his compound in Abbottabad, Pakistan, after a 10-year manhunt. The main trial of the attacks against Mohammed and his co-conspirators Walid bin Attash, Ramzi bin al-Shibh, Ammar al-Baluchi, and Mustafa Ahmad al-Hawsawi remains unresolved. Khalid Sheikh Mohammed was arrested on March 1, 2003, in Rawalpindi, Pakistan, by Pakistani security officials working with the CIA. He was then held at multiple CIA secret prisons and Guantanamo Bay detention camp, where he was interrogated and tortured with methods including waterboarding. In 2003, al-Hawsawi and Abd al-Aziz Ali were arrested and transferred to U.S. custody. Both would later be accused of providing money and travel assistance to the hijackers. During U.S. hearings at Guantanamo Bay in March 2007, Mohammed again confessed his responsibility for the attacks, stating he "was responsible for the 9/11 operation from A to Z" and that his statement was not made under duress. In January 2023, the U.S. government opened up about a potential plea deal, with Biden giving up on the effort in September that year. To date, only peripheral persons have thus been convicted for charges in connection with the attacks. These include:

=== Gene gun === Gene gun delivery ballistically accelerates plasmid DNA (pDNA) that has been absorbed onto gold or tungsten microparticles into the target cells, using compressed helium as an accelerant.

Sources: en.wikipedia.org

Background from the literature

== Effectiveness == A landmark randomized placebo control trial on NASHA Dx was published in 2011 in the Lancet. 136 were given real injections and 70 patients were given shame (fake) injections. 80% of the patients had no improvement 1 month after the procedure, and were given a second injection. After 6 months, 52% of patients who received real injections had improved symptoms. However, the patients who received fake injections reported over 30% improvement in symptoms, suggesting that patient psychology (i.e. the placebo effect) may be in part responsible for any positive results. 6% of patients who received real injections were fully continent after 6 months. After publication of this study, the material was approved by the FDA in the USA in 2012. The material was aggressively marketed, and became popular for a time because of its potential as an in office treatment with low risks compared to other surgical options. However uncertainty about indications, cost, and long term durability stopped widespread adoption. A Cochrane systematic review of the efficacy of this type of treatment for FI was updated in 2013. The review included 5 randomized trials, which in total was 382 patients. 4 of the trials were assessed as uncertain or high risk of bias. Another commentator drew attention to the fact that all existing research on these procedures was driven by the companies who also marketed the treatments, and therefore the studies are indeed at high risk of bias.

=== Anxiety === Buspirone is used for the short-term and long-term treatment of anxiety disorders or symptoms of anxiety. It is typically as a second-line or augmentation therapy, notable for having a favorable side-effect profile and no risk of dependence. Buspirone has no immediate anxiolytic effects, and hence has a delayed onset of action; its full clinical effectiveness may require 2–4 weeks to manifest itself. Buspirone is an effective and generally well-tolerated treatment for generalized anxiety disorder (GAD); evidence is limited by small sample size. Buspirone is associated with side effects like dizziness, constipation, and gastric distress; it also demonstrates cognitive benefits (especially in visual learning and memory, logical reasoning, and attention). Buspirone is not known to be effective in the treatment of anxiety disorders other than GAD.

Saddiction's sound encompasses elements of dark metal, shoegaze, pop, gothic rock, post-rock and alternative rock. In 2025, Mills drew a parallel between their melodies and those of the Sisters of Mercy, but with guitar distortion and drums' "fierceness" turned up in Hangman's Chair.

Generative artificial intelligence has been applied across multiple industries for content creation and automation. In healthcare, generative models are used for drug discovery and the generation of synthetic medical data to train diagnostic systems. In finance, they are used for report drafting, data generation, and customer service automation. Media and entertainment industries use generative systems for tasks such as music composition, script development, and image or video generation. Researchers and policymakers have raised concerns regarding accuracy, misuse, and impacts on academic and professional work.

The gastrointestinal tract has a form of general histology with some differences that reflect the specialization in functional anatomy. The GI tract can be divided into four concentric layers in the following order:

Sources: en.wikipedia.org

Reference notes

== Research and advocacy == The Muscular Dystrophy Association (MDA) is involved in research, advocacy, and services for individuals affected by muscular dystrophy. The organization provides resources that contribute to understanding and addressing this condition.

== Work == Development of dedicated machinery for insulin extraction and purification at the Zoophysiology Laboratory workshop. Design and implementation of early insulin delivery technologies (the "Novo Syringe" for self-injection). Co-development of Insulin Novo, marketed by Novo Terapeutisk in the mid-1920s.

== Habitat and distribution == Xanthoria parietina is a cosmopolitan species reported from Australia, Africa, Asia, North America, and throughout much of Europe. In eastern North America and Europe, it is more frequently encountered near coastal locations, and in Southern Ontario, Canada, its reappearance has been attributed to increased nitrate deposition associated with industrial and agricultural developments. The species shows a strong preference for coastal habitats, where it benefits from marine aerosol deposition. In Maine, USA, X. parietina is abundant on gravestones near the ocean but declines sharply further inland. It becomes rare beyond 40 km (25 mi) from the coast in southwestern Maine and 130 km (81 mi) inland in eastern Maine. This inland distribution pattern is largely influenced by the deposition of marine-derived nutrients, particularly chloride and sodium, which are transported inland by wind and precipitation. In North America, the species was historically limited primarily to coastal regions—along the Atlantic coast from Newfoundland to Pennsylvania, along the Pacific coast from California to the Pacific Northwest, and in a small part of the Gulf coast in Texas. Within the Pacific Northwest, its traditional range was described as west of the Cascades, from the Willamette Valley to the Puget Sound region. Since the early 2000s, however, the species has been documented in several inland cities in Idaho, Washington, and parts of western Montana.

As such, the HPA axis starts to become suppressed and atrophy. If this occurs the patient should be tapered off prednisone slowly to give the adrenal gland enough time to regain its function and endogenous production of steroids.

The Arizona Thunder was a professional indoor soccer team based in Phoenix, Arizona, United States. In 1997, the team was a member of the Premier Soccer Alliance. In 1998, the alliance, with some additional teams, reconstituted itself as the World Indoor Soccer League (WISL). The Thunder continued to play in the WISL from 1998 to 2000. The team played in the Arizona Veterans Memorial Coliseum. Many of the players grew up and played youth soccer in AZ including Randy Soderman, Rick Soderman, Jason Vanacour, Milo Iniguez, Mark Kerlin, Derick Brownell, Kenneth Wright (Thea), Sasha Hunter, Dave Cameron, Kevin Berry, Donny Gaillard, Greg Veatch along with many implants like Milos Tomic, Chris Sagar, Roger Salazar, Victor Gilgan,Chris Scotti, Tom Bratcher and the Dunn Brothers. Some games were televised on COX 9 In 1999 and in 2000. During the Thunder's three years in the WISL they averaged attendance of 4,261 fans per game.

Sources: en.wikipedia.org

Frequently asked questions

What is GHK-Cu?

It is the copper complex of the tripeptide glycyl-L-histidyl-lysine. The metal ion is held by the histidine imidazole group and the peptide N-terminus. Most research on it concerns skin and wound models.

Where does the GHK sequence come from?

The tripeptide was first isolated from human plasma and has also been reported in saliva and urine. Plasma levels appear to decline with age in some small studies. Those observations rest on limited sample sizes.

Is GHK-Cu an approved drug?

It is not authorized as a systemic medicine in most countries. Cosmetic preparations list it as an ingredient rather than an active pharmaceutical substance. Legal status therefore differs by jurisdiction.

Is GHK-Cu an approved drug?

It is not approved as a pharmaceutical in major markets and is used mainly as a cosmetic ingredient and a laboratory reagent. Regulatory status varies by country and by the product category in which it appears. Claims about therapeutic effects should be treated separately from permitted cosmetic labeling.

Network